[Skip to Content]
[Skip to Content Landing]
Article
July 1980

Gentamicin-Resistant Serratia marcescens Endophthalmitis

Author Affiliations

From the Department of Ophthalmology, Pacific Medical Center, San Francisco (Drs Gammon and Schwab), and the Division of Infectious Diseases, San Francisco General Hospital (Dr Joseph).

Arch Ophthalmol. 1980;98(7):1221-1223. doi:10.1001/archopht.1980.01020040073007
Abstract

• In a case of metastatic Gram-negative endophthalmitis caused by Serratia marcescens, the bacterial isolate was resistant to gentamicin sulfate and tobramycin but sensitive to amikacin sulfate, a new semisynthetic aminoglycoside approved for systemic use. The importance of antibiotic-resistant S marcescens as a systemic and ocular pathogen is reviewed.

×